Hypothesis

Aging-related cognitive rigidity stems from excessive perineuronal net (PNN) accumulation that locks hippocampal circuits into a high-confidence, low-surprise state. We propose that transient, localized digestion of PNNs by chondroitinase ABC (ChABC) combined with scheduled exposure to high-uncertainty environmental stimuli will re-engage NMDA-dependent, input-specific long-term potentiation (LTP) without causing neurodegeneration.

Mechanistic Rationale

1. PNNs gate plasticity – PNNs surround parvalbumin-positive interneurons, limiting their ability to modulate spike timing and thereby shifting LTP from NMDA-receptor-dependent to L-type voltage-gated calcium channel (LVGCC)-dependent forms【4】.
2. LVGCC-dependent LTP is input-non-specific – High-frequency stimulation in aged mice produces potentiation that spreads across synapses and is reversible by LVGCC blockade, indicating a loss of pattern separation capacity【4】.
3. Synaptic substrates remain intact – Stereological counts show no age-related synapse loss in hippocampal CA1 despite memory deficits, supporting a functional rather than structural deficit【5】.
4. Experience-dependent PNN remodeling – During development, sensory-driven activity reduces PNN density via neural-activity-dependent secretion of matrix metalloproteinases; a similar activity-dependent pathway likely persists in adulthood and can be harnessed exogenously.

Thus, removing the extracellular barrier restores interneuron-mediated gamma oscillations, re-instating the temporal window for NMDA-dependent coincidence detection. Pairing this with novelty-driven prediction errors provides the excitatory drive needed to shift the calcium signal back to NMDA receptors.

Testable Predictions

• Prediction 1: In aged mice (24-month), bilateral hippocampal injection of ChABC will increase WFA-negative PNN area by ≥30% relative to saline controls within 7 days【1】.
• Prediction 2: ChABC-treated aged mice exposed to a novel-object rotation schedule (daily 10-min exposure to rearranged objects) will show a shift from LVGCC-dependent to NMDA-dependent LTP in hippocampal slices, demonstrated by sensitivity to APV but resistance to nifedipine【4】.
• Prediction 3: Behavioral assays of pattern separation (e.g., spontaneous location recognition with similar contexts) will improve to young-adult levels only in the combined ChABC + novelty group; ChABC alone or novelty alone will produce negligible change.
• Prediction 4: No increase in markers of neurodegeneration (e.g., Fluoro-Joy, caspase-3) or ectopic sprouting will be detected after treatment, confirming structural preservation【5】.

Experimental Design

• Subjects: Male and female C57BL/6 mice, 12-month (young) and 24-month (aged) cohorts.
• Groups (n=10 per age × condition): (1) Saline + home-cage, (2) ChABC + home-cage, (3) Saline + novelty schedule, (4) ChABC + novelty schedule.
• Procedure: Stereotactic hippocampal delivery of 0.5 U ChABC in 0.5 µL ACSF per side; novelty schedule begins 24 h post-injection and continues for 14 days.
• Readouts: (a) PNN immunostaining (WFA/ACAN) quantification; (b) In-vitro LTP assays with pharmacological isolation of NMDA vs LVGCC components; (c) In-vivo hippocampal gamma power during novelty exposure (EEG); (d) Behavioral pattern separation and reversal learning tasks.

Falsifiability

If ChABC fails to reduce PNN density, or if LVGCC-dependent LTP persists despite PNN removal, the hypothesis that PNNs are the primary gate of age-related plasticity shift is falsified. Likewise, if novelty exposure alone restores NMDA-dependent LTP, the necessity of extracellular matrix digestion is challenged. Conversely, detection of significant neuronal loss or ectopic axonal sprouting would indicate that PNN removal compromises circuit integrity, refuting the claim that aging hippocampus is structurally intact.

Broader Implications

Success would validate a "controlled uncertainty" intervention: brief pharmacological matrix loosening coupled with environmental surprise re-tunes the brain’s confidence-vs-flexibility balance, offering a non-invasive strategy to counteract cognitive rigidity without attempting to restore lost neurons.

References

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC12628600/ [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC11296138/ [3] https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2020.00027/full [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC11330810/ [5] https://pmc.ncbi.nlm.nih.gov/articles/PMC3592200/ [6] https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2010.00026/full